Continuing medical education
Physicians recognize the need for ever-continuing medical education. This recognition is based upon the rapid, even explosive, new information relating to diagnosis and treatment of disease.
There is, arguably, no area in medicine that matches oncology in the burgeoning of new and improved therapy. As one who has participated in an experimental clinical trial usiing radioimmunotherapy (RIT) as first-line (or front-line) therapy for non-Hodgkin's lymphoma, I feel that in some small way I have contributed to the education of oncologists.
More significant, perhaps, is the need for oncologists to attend and partiicipate in formal educational conferences in which leaders in lymphoma research present their latest data and opinions. Betsy and I, beneficiaries of RIT for Stage IV lymphoma, are vigorous activists in promoting lymphoma education.
Mort